Corcept Therapeutics (CORT) Gross Margin Growth (5y) (2017 - 2026)

Corcept Therapeutics (CORT) Gross Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Corcept Therapeutics 9.56 Bn 9.22 Bn 162.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.00
Dec 31, 2025 20.00
Sep 30, 2025 -80.00
Jun 30, 2025 -37.00
Mar 31, 2025 49.00
Dec 31, 2024 1.00
Sep 30, 2024 21.00
Jun 30, 2024 36.00
Mar 31, 2024 19.00
Dec 31, 2023 98.00
Sep 30, 2023 70.00
Jun 30, 2023 51.00
Mar 31, 2023 72.00
Dec 31, 2022 74.00
Sep 30, 2022 97.00
Jun 30, 2022 91.00
Mar 31, 2022 101.00
Dec 31, 2021 99.00
Sep 30, 2021 175.00
Jun 30, 2021 65.00